These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 17548524)

  • 1. Complement factor H and the hemolytic uremic syndrome.
    Atkinson JP; Goodship TH
    J Exp Med; 2007 Jun; 204(6):1245-8. PubMed ID: 17548524
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Complement activation in diseases presenting with thrombotic microangiopathy.
    Meri S
    Eur J Intern Med; 2013 Sep; 24(6):496-502. PubMed ID: 23743117
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inherited complement regulatory protein deficiency predisposes to human disease in acute injury and chronic inflammatory statesthe examples of vascular damage in atypical hemolytic uremic syndrome and debris accumulation in age-related macular degeneration.
    Richards A; Kavanagh D; Atkinson JP
    Adv Immunol; 2007; 96():141-77. PubMed ID: 17981206
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Spontaneous hemolytic uremic syndrome triggered by complement factor H lacking surface recognition domains.
    Pickering MC; de Jorge EG; Martinez-Barricarte R; Recalde S; Garcia-Layana A; Rose KL; Moss J; Walport MJ; Cook HT; de Córdoba SR; Botto M
    J Exp Med; 2007 Jun; 204(6):1249-56. PubMed ID: 17517971
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of complement in AMD.
    Zipfel PF; Lauer N; Skerka C
    Adv Exp Med Biol; 2010; 703():9-24. PubMed ID: 20711704
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The complement fitness factor H: role in human diseases and for immune escape of pathogens, like pneumococci.
    Zipfel PF; Hallström T; Hammerschmidt S; Skerka C
    Vaccine; 2008 Dec; 26 Suppl 8():I67-74. PubMed ID: 19388168
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Complement and diseases: defective alternative pathway control results in kidney and eye diseases.
    Zipfel PF; Heinen S; Józsi M; Skerka C
    Mol Immunol; 2006 Jan; 43(1-2):97-106. PubMed ID: 16026839
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Complement factor H related proteins in immune diseases.
    Skerka C; Zipfel PF
    Vaccine; 2008 Dec; 26 Suppl 8():I9-14. PubMed ID: 19388158
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Translational mini-review series on complement factor H: renal diseases associated with complement factor H: novel insights from humans and animals.
    Pickering MC; Cook HT
    Clin Exp Immunol; 2008 Feb; 151(2):210-30. PubMed ID: 18190458
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of complement factor H-related (CFHR) proteins in plasma reveals novel genetic variations of CFHR1 associated with atypical hemolytic uremic syndrome.
    Abarrategui-Garrido C; Martínez-Barricarte R; López-Trascasa M; de Córdoba SR; Sánchez-Corral P
    Blood; 2009 Nov; 114(19):4261-71. PubMed ID: 19745068
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of defective complement control in hemolytic uremic syndrome.
    Zipfel PF; Misselwitz J; Licht C; Skerka C
    Semin Thromb Hemost; 2006 Mar; 32(2):146-54. PubMed ID: 16575689
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An interactive web database of factor H-associated hemolytic uremic syndrome mutations: insights into the structural consequences of disease-associated mutations.
    Saunders RE; Goodship TH; Zipfel PF; Perkins SJ
    Hum Mutat; 2006 Jan; 27(1):21-30. PubMed ID: 16281287
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The interactive Factor H-atypical hemolytic uremic syndrome mutation database and website: update and integration of membrane cofactor protein and Factor I mutations with structural models.
    Saunders RE; Abarrategui-Garrido C; Frémeaux-Bacchi V; Goicoechea de Jorge E; Goodship TH; López Trascasa M; Noris M; Ponce Castro IM; Remuzzi G; Rodríguez de Córdoba S; Sánchez-Corral P; Skerka C; Zipfel PF; Perkins SJ
    Hum Mutat; 2007 Mar; 28(3):222-34. PubMed ID: 17089378
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Complement factor H related proteins (CFHRs).
    Skerka C; Chen Q; Fremeaux-Bacchi V; Roumenina LT
    Mol Immunol; 2013 Dec; 56(3):170-80. PubMed ID: 23830046
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Atypical haemolytic uraemic syndrome and mutations in complement regulator genes.
    Dragon-Durey MA; Frémeaux-Bacchi V
    Springer Semin Immunopathol; 2005 Nov; 27(3):359-74. PubMed ID: 16189652
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Factor H genotype-phenotype correlations: lessons from aHUS, MPGN II, and AMD.
    Goodship TH
    Kidney Int; 2006 Jul; 70(1):12-3. PubMed ID: 16810287
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Translational mini-review series on complement factor H: genetics and disease associations of human complement factor H.
    de Córdoba SR; de Jorge EG
    Clin Exp Immunol; 2008 Jan; 151(1):1-13. PubMed ID: 18081690
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New treatment options for atypical hemolytic uremic syndrome with the complement inhibitor eculizumab.
    Köse O; Zimmerhackl LB; Jungraithmayr T; Mache C; Nürnberger J
    Semin Thromb Hemost; 2010 Sep; 36(6):669-72. PubMed ID: 20865644
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The endothelial glycocalyx as a potential modifier of the hemolytic uremic syndrome.
    Boels MG; Lee DH; van den Berg BM; Dane MJ; van der Vlag J; Rabelink TJ
    Eur J Intern Med; 2013 Sep; 24(6):503-9. PubMed ID: 23357408
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Factor H family proteins and human diseases.
    Józsi M; Zipfel PF
    Trends Immunol; 2008 Aug; 29(8):380-7. PubMed ID: 18602340
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.